
Hikma Pharmaceuticals Hits Day Low of GBP 15.22 Amid Price Pressure
2025-11-07 17:07:10Hikma Pharmaceuticals Plc has faced notable stock volatility, hitting an intraday low and experiencing significant declines over various timeframes. Despite maintaining high management efficiency and a low debt-to-equity ratio, the company is challenged by rising raw material costs and a substantial drop in pre-tax profit.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






